Result of AGM

RUA Life Sciences PLC
28 August 2024
 

28 August 2024

                     

RUA Life Sciences plc

("RUA" the "Company" or the "Group")

Result of AGM

 

RUA Life Sciences plc (AIM:RUA.L), the holding company of a group of medical device businesses focussed on the exploitation of the world's leading long-term implantable biostable polymer (Elast-Eon ™), announces that all resolutions put forward to its Annual General Meeting held yesterday were duly passed and the votes cast were as follows:

 

Res No.

Votes For

%

Votes Against

%

Votes Withheld

01

6,051,300

99.37%

38,570

0.63%

0

02

6,050,279

99.36%

38,783

0.64%

808

03

6,051,300

99.37%

38,570

0.63%

0

04

6,045,927

99.28%

43,943

0.72%

0

05

6,045,698

99.27%

44,172

0.73%

0

06

5,941,757

97.57%

148,113

2.43%

0

07

5,941,757

97.57%

148,113

2.43%

0

 

The full text of each of the resolutions is set out in the notice of Annual General Meeting, copies of which are available on the Company's website (www.rualifesciences.com).

 

For further information contact:

RUA Life Sciences

Tel: +44 (0)1294 317073

Bill Brown, CEO


Lachlan Smith, CFO




Cavendish Capital Markets Limited


(Nominated Adviser and Broker)

Tel: +44 (0)20 7220 0500

Giles Balleny/Dan Hodkinson (Corporate Finance)


Charlie Combe (Broking)


Michael Johnson (Sales)


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings